Security key
68062P106
Olema Pharmaceuticals, Inc. - COMMON STOCK (OLMA)
CUSIP: 68062P106
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 56,110,675
- Total 13F value
- $635,162,151
- Share change
- +4,484,144
- Put/Call ratio
- 75%
- SEC-reported price per share
- $11.32
- Number of holders
- 125
- Value change
- +$37,635,929
- Number of buys
- 68
- Number of sells
- 52
- Shares outstanding
- 87,500,447
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
125
Top holders
10
OLMA full security history
Ownership snapshot
Full 13F holder table
Olema Pharmaceuticals, Inc. SEC filings
Olema Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of OLMA - Olema Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 10%
Showing 1-6 of 15 holder rows.
Quick read
BVF INC/IL leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Comparable ownership
Top 5
BVF INC/IL
10%
Paradigm Biocapital Advisors LP
9%
Logos Global Management LP
5%
BlackRock Finance, Inc.
3.7%
VANGUARD GROUP INC
3.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
10%
|
$128,176,579
9,135,893 shares
|
— | 31 Dec 2023 |
| Paradigm Biocapital Advisors LP |
13F
Company
|
9%
|
$110,887,508
7,903,600 shares
|
— | 31 Dec 2023 |
| Logos Global Management LP |
13F
Company
|
5%
|
$54,376,702
4,383,875 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
3.7%
|
$45,792,615
3,263,907 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
3.1%
|
$37,963,707
2,705,895 shares
|
— | 31 Dec 2023 |
| Cormorant Asset Management, LP |
13F
Company
|
2.8%
|
$34,468,904
2,456,800 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
125
Shares
56,110,675
Rows available
125
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
125
Q1 2024 holders
125
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|